The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Brief Title: A Registry for BRCA Mutation Carriers With Pancreatic Ductal Adenocarcinoma
Official Title: A Registry for BRCA Mutation Carriers With Pancreatic Ductal Adenocarcinoma
Study ID: NCT01983410
Brief Summary: The purpose of this study is to better understand why pancreatic cancer develops in some people who are known carriers of the gene mutation (an abnormality) called BRCA, or its close relative PALB2. The investigators hope to do this by establishing a BRCA/PALB2 mutation carriers Pancreatic Ductal Adenocarcinoma (the common form of pancreatic cancer) Registry. A registry is a database of information.
Detailed Description:
Minimum Age: 21 Years
Eligible Ages: ADULT, OLDER_ADULT
Sex: ALL
Healthy Volunteers: Yes
Memorial Sloan Kettering Basking Ridge, Basking Ridge, New Jersey, United States
Memorial Sloan Kettering Monmouth, Middletown, New Jersey, United States
Memorial Sloan Kettering Bergen, Montvale, New Jersey, United States
Cold Springs Harbor Laboratory (Specimen Analysis), Cold Spring Harbor, New York, United States
Memorial Sloan Kettering Commack, Commack, New York, United States
Memorial Sloan Kettering Westchester, Harrison, New York, United States
Memorial Sloan Kettering Cancer Center, New York, New York, United States
Weill Cornell Medical College (Specimen Analysis), New York, New York, United States
Memorial Sloan Kettering Nassau, Uniondale, New York, United States
Abramson Cancer Center at University of Pennsylvania Medical Center, Philadelphia, Pennsylvania, United States
Shaare Zedek Medical Center, Jerusalem, , Israel
Weizmann Institute of Science (Specimen Analysis), Reẖovot, , Israel
Sheba Medical Center, Tel Hashomer, , Israel
Name: David Kelsen, MD
Affiliation: Memorial Sloan Kettering Cancer Center
Role: PRINCIPAL_INVESTIGATOR